arrow
E

Elmar Aigner

university hospital salzburg
H指数:42
被引数:8,077

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Poor self-rated health is twice as common in rheumatoid arthritis: population-based evidence from the Paracelsus 10,000 study

类风湿关节炎患者自评健康状况较差的情况是普通人群的两倍:来自Paracelsus 10,000研究的基于人群的证据

2026-06-200
OA
Chronic hepatitis D in Austria: high burden of cirrhosis and portal hypertension, IL28B C/C as unfavorable factor, increased systemic inflammation in decompensation

奥地利慢性丁型肝炎:肝硬化与门静脉高压负担沉重,IL28B C/C为不利因素,失代偿期系统性炎症增加

2026-02-010
OAAI
A Longitudinal Investigation of Prediabetes, Diabetes, HbA1c and Cognitive Trajectories Among Cognitively Unimpaired Individuals

对认知功能完好个体中糖尿病前期、糖尿病、HbA1c及认知轨迹的纵向研究

2025-12-010
PRE
PNPLA3 and TM6SF2 exacerbate the impact of alcohol and metabolic dysfunction on liver fibrosis☆

PNPLA3和TM6SF2加剧了酒精和代谢功能障碍对肝纤维化的影响☆

2025-10-300
OAAI
Rheumatoid arthritis is independently associated with metabolic Dysfunction-Associated steatotic liver disease: evidence from the paracelsus 10,000 Population-Based cohort study

类风湿关节炎与代谢功能障碍相关脂肪性肝病独立相关:来自帕拉塞尔苏斯10,000人群队列研究的证据

2025-10-060
OA
Association between depression and metabolic dysfunction-associated steatotic liver disease: a cross-sectional analysis from the paracelsus 10,000 Study

抑郁与代谢功能障碍相关脂肪性肝病之间的关联:一项来自帕拉塞尔苏斯10,000研究的横断面分析

2025-10-010
OA
Austrian multisociety consensus on metabolic dysfunction-associated steatotic liver disease

奥地利多学会关于代谢功能障碍相关脂肪性肝病的共识

2025-10-010
OAAI
Prevalence of fibrosis and applicability of lab-based non-invasive tests from primary to tertiary care

纤维化患病率及实验室基础无创检测在初级至三级医疗中的适用性

2025-09-160
OAAI
Assessing the role of polygenic risk scores in cardiovascular risk prediction: a cross-sectional analysis from the Paracelsus 10 000 cohort

评估多基因风险评分在心血管风险预测中的作用:一项来自Paracelsus 10 000队列的横断面分析

2025-04-080
PRE
Lipid Dysregulation in Tangier Disease: A Case Series and Metabolic Characterization

丹吉尔病的脂质失调: 病例系列和代谢特征

2025-03-010
OA